DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▲ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0600139 | Prostate carcinoma | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C1449563 | Cardiomyopathy, Familial Idiopathic | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0006826 | Malignant Neoplasms | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0026946 | Mycoses | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0001815 | Primary Myelofibrosis | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C4552003 | EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1 | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0008354 | Cholera | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0033578 | Prostatic Neoplasms | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C1306459 | Primary malignant neoplasm | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0002395 | Alzheimer's Disease | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0007103 | Malignant neoplasm of endometrium | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0476089 | Endometrial Carcinoma | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0341106 | Eosinophilic esophagitis | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0026850 | Muscular Dystrophy | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0024121 | Lung Neoplasms | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0024530 | Malaria | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C0231341 | Premature aging syndrome | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C0023418 | leukemia | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C0699791 | Stomach Carcinoma | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C0019163 | Hepatitis B | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C1332206 | Adult Lymphoma | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C0006826 | Malignant Neoplasms | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C0024535 | Malaria, Falciparum | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C0025289 | Meningitis | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
C0034494 | Rabies (disorder) | ENOSF1 | 55556 | enolase superfamily member 1 | Q7L5Y1 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024